HIGHLIGHTS
- who: Anne-Cecile Ezanno from the Ecole du Val de Gru00e2ce, Paris, France have published the paper: Pressurized intraperitoneal aerosol chemotherapy, reasons for interrupting treatment: a systematic review of the literature, in the Journal: (JOURNAL)
- what: Disease progression was the main reason for early termination of the treatment (49.1%). There are many reasons for discontinuing after only 1 or 2 procedures, with the main reason being the progression of the oncological disease . The aim of this study is to propose a systematic review of the literature to evaluate the number and reasons for discontinuing . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.